THE VALUE OF REGULATORY EFFECTS ON LIPID METABOLISM IN DURING COMPLICATED DIABETES MELLITUS
L.V. Natrus1, L.V. Gayova1, M.Yu. Byhovets2, Yu.S. Osadchuk1, S.E. Konovalov1
- Bogomolets National Medical University, Kyiv, Ukraine
- Shupyk National Medical Academy of Postgraduate, Education, Kyiv, Ukraine
DOI: https://doi.org/10.15407/fz66.01.025
Abstract
Exogenous and endogenous regulatory effects on lipid metabolism
were studied by examining the fatty acid (FA) composition
of food and the expression of the regulatory protein L-FABP
in 43 individuals without diabetes (23 of them had increased
blood glucose and cholesterol level and 20 formed a control
group) and 76 patients with complicated diabetes mellitus
(DM2). The main difference of lipid metabolism in patients
with diabetes mellitus and non-diabetic patients was in the
redistribution of FA content in erythrocyte membranes in the
form of a 1.5-fold increase (P<0.05) in the content of saturated
FA and decrease in unsaturated FA due to polyunsaturated FA
(PUFA) and an increase the serum protein L-FABP 1.5 times
(P>0.05). Eating food sources of various FAs according to
the indicator of “rationality of food consumption”, which
was obtained from food questionnaires analysis, did not differ
in groups of people without diabetes and with diabetes.
In the non-diabetic group with elevated blood glucose and
cholesterol level, we revealed a decreased body mass index, a
slight increase in PUFA in erythrocyte membranes and serum
level L-FABP was 1.2 times lower than in relatively healthy
subjects (P>0.05) and 2 times less than in patients with DM2
(P<0.05). It can be assumed, that under certain conditions, in
the presence of metabolic shifts, it is the reduction of L-FABP
expression with increased PUFA in cells that prevents the
development of obesity and diabetes. Thus, the absence of a
direct relationship between exogenous influences in the form
of FA-source food products and the development of diabetes,
the relationship between the expression of intracellular regulatory
protein L-FABP and the redistribution of FA content
in erythrocyte membranes allow us to consider endogenous
cellular mechanisms as the basis of a deep violation of lipid
homeostasis.
Keywords:
fatty acids, L-FABP, diet, erythrocyte membranes
References
International diabetes federation annual report 2015. https:.www.oedg.at. pdf. 1606_IDF_ Atlas_2015_UK.pdf
- Boden G, Chen X and Iqbal N. Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects. Diabetes. 1998;47(10):1609-12.
CrossRef
PubMed
- Boden G, Laakso M. Lipids and glucose in type 2 diabetes. What is the cause and effect? Diabetes Care. 2004;27(9): 2253-59.
CrossRef
PubMed
- Choromańska B, Myśliwiec P, Dadan J, Hady HR, Chabowski A. The clinical significance of fatty acid binding proteins. PostepyHig Med Dosw (Online). 2011;65:759-63.
CrossRef
PubMed
- Gajda AM, Zhou YX, Agellon LB. Direct comparison of mice null for liver- or intestinal fatty acid binding proteins reveals highly divergent phenotypic responses to high-fat feeding. J Biol Chem. 2013;288(42):30330-44.
CrossRef
PubMed PubMedCentral
- Wang Gu Qi, Bonkovsky HL, de Lemos A, Burczynski FJ. Recent insights into the biological functions of liver fatty acid binding protein 1. Lipid Res. 2015;56:2238-47.
CrossRef
PubMed PubMedCentral
- Atshaves BP, GMartin G, Hostetler HA et al. Liver fatty acid binding protein and obesity. J Nutr Biochem. 2010;21(11):1015-32.
CrossRef
PubMed PubMedCentral
- Hodson L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res. 2008;47(5):348-80.
CrossRef
PubMed
- Mann JI. Nutrition recommendations for the treatment and prevention of type 2 diabetes and the metabolic syndrome: an evidenced-based review. Nutr Rev. 2006;64(9):422-27.
CrossRef
PubMed
- Risérus U, Willett WC, Hu FB et al. Dietary fats and prevention of type 2 diabetes. Prog Lipid Res. 2009;48(1): 44-51.
CrossRef
PubMed PubMedCentral
- Rykov SO, Bykhovets MY, Natrus LV. Features of the lifestyle as a factor of the risk of development and progression of diabetic retinopathy in patients with diabetes mellitus of 2 types. ArkhOftalʹmol Ukr. 2019;5(3):54-61.
- Bykhovets M. Information value of biochemical markers for evaluation of lipid dysmetabolism secondary to hyperglycaemia in patients with diabetic retinopathy and type 2 diabetes mellitus. East Eur Sci J (Warsaw, Poland). 2019;9(49). 1:19-25.
- Frota KMG, Matias ACG, Arêas JAG. Influence of food components on lipid metabolism: scenarios and perspective on the control and prevention of dyslipidemias. Food Sci Technol. 2010;30(Suppl. 1), 7-14.
CrossRef
- Camargo A, Meneses ME, Pérez-Martínez P, et al. Dietary fat modifies lipid metabolism in the adipose tissue of metabolic syndrome patients. Genes Nutr. 2014;9(4):409.
CrossRef
PubMed PubMedCentral
- Tovar AR, Díaz-Villaseñor A, Cruz-Salazar N et al. Dietary type and amount of fat modulate lipid metabolism gene expression in liver and in adipose tissue in high-fat dietfed rats. Arch Med Res. 2011;42(6):540-53.
CrossRef
PubMed
- Shi J, Zhang Y, Gu W, Cui B, Xu M, Yan Q et al. Serum liver fatty acid binding protein levels correlate positively with obesity and insulin resistance in Chinese young adults. 2012. PLoS ONE 7(11).
CrossRef
PubMed PubMedCentral
- Wang Gu Qi, Bonkovsky HL, de Lemos A, Burczynski FJ. Recent insights into the biological functions of liver fatty acid binding protein 1. J Lipid Res. 2015;56:2238-47.
CrossRef
PubMed PubMedCentral
- McIntosha AL, Barbara P, Martina AGG. Effect of liver fatty acid binding protein (L-FABP) gene ablation on lipid metabolism in high glucose diet (HGD) pair-fed mice. Mol Cell Biol Lipids. 2019;1864(7): 985-1004.
CrossRef
PubMed
- McGarry JD. What if Minkowski had been ageusic? An alternative angle on diabetes. Science. 1992; 258,(5083):766-70.
CrossRef
PubMed
- Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia. 1992;35(7):595-601.
CrossRef
PubMed
- Benjamin SM, Valdez R, Geiss LS, Rolka DB, Narayan KM. Estimated number of adults with prediabetes in the US in 2000: opportunities for prevention. Diabetes Care. 2003;26:645-49.
CrossRef
PubMed
|